Pegteograstim

DB15290Investigational

Pegteograstim is under investigation in clinical trial NCT02787876 (Pegteograstim in Children With Solid Tumors).

Mechanism: Pharmacologically active on Granulocyte colony-stimulating factor receptor
Curator reviewed

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

8Drug interactionsStructured to mechanism, not free text

3Clinical trialsPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 3 drug categories

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Pegteograstim, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.